Pharmaceuticals

Plasma Therapy Market 2026–2035 expanding with regenerative medicine trends

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Plasma Therapy Market During 2026–2030?

The plasma therapy market has witnessed rapid growth in recent years. Its size is expected to expand from $0.61 billion in 2025 to $0.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. This historical development can be attributed to several factors such as limited awareness about plasma therapy benefits, a reliance on conventional treatments, an increase in orthopedic and sports medicine procedures, the expansion of hospital and clinic infrastructure, and the early adoption of PRP in cosmetic procedures.

The plasma therapy market is projected to experience swift expansion in the coming years, with its size reaching $1.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the creation of sophisticated PRP and PRF formulations, a surge in regenerative medicine research, broader applications of plasma therapy for chronic and cardiac injuries, increased usage in dermatology and dental fields, and the proliferation of clinical trials and research institutions. Key trends anticipated during this period encompass the increasing embrace of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the broadening of regenerative medicine and orthopedic uses, their expanding application in dermatology, hair restoration, and plastic surgery, a heightened demand for fibrin products in injectable and membrane forms, and the integration of research with clinical trials to achieve superior therapeutic results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Underlying Factors Are Accelerating The Growth Of The Plasma Therapy Market?

The increasing incidence of osteoarthritis is anticipated to propel the growth of the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is recognized as a secure and effective therapeutic option for osteoarthritis. PRP constitutes a concentrated autologous blood growth factor, administered via injection into the affected joint to alleviate symptoms by reducing inflammation and impeding the advancement of osteoarthritis. As an illustration, data from September 2023, published in the Journal of Elsevier, a Netherlands-based publishing entity, indicates that by 2050, the worldwide increase in osteoarthritis cases is forecast to reach 74.9% (with a range of 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Other prevalent treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, the growing prevalence of osteoarthritis is anticipated to stimulate the plasma therapy market.

How Are The Various Segments Of The Plasma Therapy Market Categorized?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Trends Are Affecting The Expansion Of The Plasma Therapy Market?

Leading companies within the plasma therapy market are introducing innovative products, such as the ESG-410, to address changing requirements and improve treatment possibilities. The ESG-410 functions as an Electrosurgical Generator, designed to offer versatility and efficiency in the management of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a medical technology company based in Japan, unveiled the ESG-410, its next-generation electrosurgical generator. This device is utilized for treating bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design elements, including enhanced capacitors, which guarantee superior plasma stability during the ignition process. It is notable for its rapid ignition and optimized plasma stability, presenting improvements over the ESG-400, particularly when utilized with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator facilitates advanced treatment options for NMIBC and BPH by offering a selection of resection loops, electrodes, and vaporization tools.

Which Major Firms Influence Developments In The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Read the full plasma therapy market report here:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Region Is Projected To Dominate The Plasma Therapy Market During The Forecast Period?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plasma Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795